Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Amand F. Schmidt; Lucy S. Pearce; John T. Wilkins; Juan P. Casas; Aroon D. Hingorani

doi:10.1136/heartjnl-2017-312858

Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Amand F. Schmidt^*
, Lucy S. Pearce
, John T. Wilkins
, Juan P. Casas
, Aroon D. Hingorani

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1053-1055
Number of pages	3
Journal	Heart
Volume	104
Issue number	13
DOIs	https://doi.org/10.1136/heartjnl-2017-312858
Publication status	Published - 1 Jan 2018

Access to Document

10.1136/heartjnl-2017-312858

Cite this

@article{0124775d75c8443ba18262d7703968bd,

title = "Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease",

author = "Schmidt, \{Amand F.\} and Pearce, \{Lucy S.\} and Wilkins, \{John T.\} and Casas, \{Juan P.\} and Hingorani, \{Aroon D.\}",

note = "Funding Information: Health Sciences Fellow. ADH is an NIHR Senior Investigator and is funded by the UCL Hospitals NIHR Biomedical Research Centre. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. data sharing statement All data are available at: http://www.cochrane.org/CD011748/VASC\_pcsk9-inhibitors-prevention-cardiovascular-disease. {\textcopyright} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Funding Information: funding AFS is funded by UCLH NIHR Biomedical",

year = "2018",

month = jan,

day = "1",

doi = "10.1136/heartjnl-2017-312858",

language = "English",

volume = "104",

pages = "1053--1055",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "13",

}

TY - JOUR

T1 - Cochrane corner

T2 - PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

AU - Schmidt, Amand F.

AU - Pearce, Lucy S.

AU - Wilkins, John T.

AU - Casas, Juan P.

AU - Hingorani, Aroon D.

N1 - Funding Information: Health Sciences Fellow. ADH is an NIHR Senior Investigator and is funded by the UCL Hospitals NIHR Biomedical Research Centre. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. data sharing statement All data are available at: http://www.cochrane.org/CD011748/VASC_pcsk9-inhibitors-prevention-cardiovascular-disease. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Funding Information: funding AFS is funded by UCLH NIHR Biomedical

PY - 2018/1/1

Y1 - 2018/1/1

UR - https://www.scopus.com/pages/publications/85048337179

U2 - 10.1136/heartjnl-2017-312858

DO - 10.1136/heartjnl-2017-312858

M3 - Editorial

C2 - 29444808

AN - SCOPUS:85048337179

SN - 1355-6037

VL - 104

SP - 1053

EP - 1055

JO - Heart

JF - Heart

IS - 13

ER -

Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Access to Document

Other files and links

Cite this